AXIAL SPONDYLOARTHRITIS
Clinical trials for AXIAL SPONDYLOARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new AXIAL SPONDYLOARTHRITIS trials appear
Sign up with your email to follow new studies for AXIAL SPONDYLOARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot vs. IV drip: which arthritis treatment works better?
Disease control Recruiting nowThis study is testing if giving the arthritis drug bimekizumab through an IV (into a vein) works as well as the standard injection under the skin. It will involve about 392 adults with active psoriatic arthritis or axial spondyloarthritis. The main goal is to see if the drug leve…
Matched conditions: AXIAL SPONDYLOARTHRITIS
Phase: PHASE1 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New drug trial offers hope for Tough-to-Treat arthritis
Disease control Recruiting nowThis study is testing an investigational drug called SPY002-072 to see if it can reduce disease activity in adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis. It will compare the drug to a placebo in about 285 particip…
Matched conditions: AXIAL SPONDYLOARTHRITIS
Phase: PHASE2 • Sponsor: Spyre Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Moms on arthritis drug help science understand breastfeeding safety
Knowledge-focused Recruiting nowThis study aims to measure how much of the medication bimekizumab (Bimzelx®) passes into breast milk. It will enroll 20 breastfeeding mothers who are already using this drug to treat conditions like psoriasis or arthritis. Researchers will collect breast milk samples over several…
Matched conditions: AXIAL SPONDYLOARTHRITIS
Phase: PHASE1 • Sponsor: UCB Biopharma SRL • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC